191 related articles for article (PubMed ID: 23200536)
1. Molecular genetics of AML.
Link DC
Best Pract Res Clin Haematol; 2012 Dec; 25(4):409-14. PubMed ID: 23200536
[TBL] [Abstract][Full Text] [Related]
2. Genomics of AML: clinical applications of next-generation sequencing.
Welch JS; Link DC
Hematology Am Soc Hematol Educ Program; 2011; 2011():30-5. PubMed ID: 22160009
[TBL] [Abstract][Full Text] [Related]
3. Clonal evolution in relapsed acute myeloid leukaemia revealed by whole-genome sequencing.
Ding L; Ley TJ; Larson DE; Miller CA; Koboldt DC; Welch JS; Ritchey JK; Young MA; Lamprecht T; McLellan MD; McMichael JF; Wallis JW; Lu C; Shen D; Harris CC; Dooling DJ; Fulton RS; Fulton LL; Chen K; Schmidt H; Kalicki-Veizer J; Magrini VJ; Cook L; McGrath SD; Vickery TL; Wendl MC; Heath S; Watson MA; Link DC; Tomasson MH; Shannon WD; Payton JE; Kulkarni S; Westervelt P; Walter MJ; Graubert TA; Mardis ER; Wilson RK; DiPersio JF
Nature; 2012 Jan; 481(7382):506-10. PubMed ID: 22237025
[TBL] [Abstract][Full Text] [Related]
4. Recurring mutations found by sequencing an acute myeloid leukemia genome.
Mardis ER; Ding L; Dooling DJ; Larson DE; McLellan MD; Chen K; Koboldt DC; Fulton RS; Delehaunty KD; McGrath SD; Fulton LA; Locke DP; Magrini VJ; Abbott RM; Vickery TL; Reed JS; Robinson JS; Wylie T; Smith SM; Carmichael L; Eldred JM; Harris CC; Walker J; Peck JB; Du F; Dukes AF; Sanderson GE; Brummett AM; Clark E; McMichael JF; Meyer RJ; Schindler JK; Pohl CS; Wallis JW; Shi X; Lin L; Schmidt H; Tang Y; Haipek C; Wiechert ME; Ivy JV; Kalicki J; Elliott G; Ries RE; Payton JE; Westervelt P; Tomasson MH; Watson MA; Baty J; Heath S; Shannon WD; Nagarajan R; Link DC; Walter MJ; Graubert TA; DiPersio JF; Wilson RK; Ley TJ
N Engl J Med; 2009 Sep; 361(11):1058-66. PubMed ID: 19657110
[TBL] [Abstract][Full Text] [Related]
5. The origin and evolution of mutations in acute myeloid leukemia.
Welch JS; Ley TJ; Link DC; Miller CA; Larson DE; Koboldt DC; Wartman LD; Lamprecht TL; Liu F; Xia J; Kandoth C; Fulton RS; McLellan MD; Dooling DJ; Wallis JW; Chen K; Harris CC; Schmidt HK; Kalicki-Veizer JM; Lu C; Zhang Q; Lin L; O'Laughlin MD; McMichael JF; Delehaunty KD; Fulton LA; Magrini VJ; McGrath SD; Demeter RT; Vickery TL; Hundal J; Cook LL; Swift GW; Reed JP; Alldredge PA; Wylie TN; Walker JR; Watson MA; Heath SE; Shannon WD; Varghese N; Nagarajan R; Payton JE; Baty JD; Kulkarni S; Klco JM; Tomasson MH; Westervelt P; Walter MJ; Graubert TA; DiPersio JF; Ding L; Mardis ER; Wilson RK
Cell; 2012 Jul; 150(2):264-78. PubMed ID: 22817890
[TBL] [Abstract][Full Text] [Related]
6. Mutational spectrum and risk stratification of intermediate-risk acute myeloid leukemia patients based on next-generation sequencing.
Wang B; Liu Y; Hou G; Wang L; Lv N; Xu Y; Xu Y; Wang X; Xuan Z; Jing Y; Li H; Jin X; Deng A; Wang L; Gao X; Dou L; Liang J; Chen C; Li Y; Yu L
Oncotarget; 2016 May; 7(22):32065-78. PubMed ID: 27062340
[TBL] [Abstract][Full Text] [Related]
7. Acute myeloid leukaemia: a paradigm for the clonal evolution of cancer?
Grove CS; Vassiliou GS
Dis Model Mech; 2014 Aug; 7(8):941-51. PubMed ID: 25056697
[TBL] [Abstract][Full Text] [Related]
8. Rapid expansion of preexisting nonleukemic hematopoietic clones frequently follows induction therapy for de novo AML.
Wong TN; Miller CA; Klco JM; Petti A; Demeter R; Helton NM; Li T; Fulton RS; Heath SE; Mardis ER; Westervelt P; DiPersio JF; Walter MJ; Welch JS; Graubert TA; Wilson RK; Ley TJ; Link DC
Blood; 2016 Feb; 127(7):893-7. PubMed ID: 26631115
[TBL] [Abstract][Full Text] [Related]
9. Clonal evolution of acute myeloid leukemia highlighted by latest genome sequencing studies.
Zhang X; Lv D; Zhang Y; Liu Q; Li Z
Oncotarget; 2016 Sep; 7(36):58586-58594. PubMed ID: 27474172
[TBL] [Abstract][Full Text] [Related]
10. Clonal evolution of pre-leukemic hematopoietic stem cells precedes human acute myeloid leukemia.
Majeti R
Best Pract Res Clin Haematol; 2014; 27(3-4):229-34. PubMed ID: 25455271
[TBL] [Abstract][Full Text] [Related]
11. Clonal evolution of preleukemic hematopoietic stem cells precedes human acute myeloid leukemia.
Jan M; Snyder TM; Corces-Zimmerman MR; Vyas P; Weissman IL; Quake SR; Majeti R
Sci Transl Med; 2012 Aug; 4(149):149ra118. PubMed ID: 22932223
[TBL] [Abstract][Full Text] [Related]
12. Potential of whole-genome sequencing for determining risk and personalizing therapy: focus on AML.
Borate U; Absher D; Erba HP; Pasche B
Expert Rev Anticancer Ther; 2012 Oct; 12(10):1289-97. PubMed ID: 23176617
[TBL] [Abstract][Full Text] [Related]
13. Genetic and epigenetic heterogeneity in acute myeloid leukemia.
Li S; Mason CE; Melnick A
Curr Opin Genet Dev; 2016 Feb; 36():100-6. PubMed ID: 27162099
[TBL] [Abstract][Full Text] [Related]
14. Are results of targeted gene sequencing ready to be used for clinical decision making for patients with acute myelogenous leukemia?
Rao AV; Smith BD
Curr Hematol Malig Rep; 2013 Jun; 8(2):149-55. PubMed ID: 23595294
[TBL] [Abstract][Full Text] [Related]
15. Clonal evolution of preleukemic hematopoietic stem cells in acute myeloid leukemia.
Sykes SM; Kokkaliaris KD; Milsom MD; Levine RL; Majeti R
Exp Hematol; 2015 Dec; 43(12):989-92. PubMed ID: 26455528
[TBL] [Abstract][Full Text] [Related]
16. Whole-exome sequencing reveals the spectrum of gene mutations and the clonal evolution patterns in paediatric acute myeloid leukaemia.
Shiba N; Yoshida K; Shiraishi Y; Okuno Y; Yamato G; Hara Y; Nagata Y; Chiba K; Tanaka H; Terui K; Kato M; Park MJ; Ohki K; Shimada A; Takita J; Tomizawa D; Kudo K; Arakawa H; Adachi S; Taga T; Tawa A; Ito E; Horibe K; Sanada M; Miyano S; Ogawa S; Hayashi Y
Br J Haematol; 2016 Nov; 175(3):476-489. PubMed ID: 27470916
[TBL] [Abstract][Full Text] [Related]
17. RNA Splicing Modulation Selectively Impairs Leukemia Stem Cell Maintenance in Secondary Human AML.
Crews LA; Balaian L; Delos Santos NP; Leu HS; Court AC; Lazzari E; Sadarangani A; Zipeto MA; La Clair JJ; Villa R; Kulidjian A; Storb R; Morris SR; Ball ED; Burkart MD; Jamieson CHM
Cell Stem Cell; 2016 Nov; 19(5):599-612. PubMed ID: 27570067
[TBL] [Abstract][Full Text] [Related]
18. Perspective on how to approach molecular diagnostics in acute myeloid leukemia and myelodysplastic syndromes in the era of next-generation sequencing.
Kohlmann A; Bacher U; Schnittger S; Haferlach T
Leuk Lymphoma; 2014 Aug; 55(8):1725-34. PubMed ID: 24144312
[TBL] [Abstract][Full Text] [Related]
19. Role of TP53 mutations in the origin and evolution of therapy-related acute myeloid leukaemia.
Wong TN; Ramsingh G; Young AL; Miller CA; Touma W; Welch JS; Lamprecht TL; Shen D; Hundal J; Fulton RS; Heath S; Baty JD; Klco JM; Ding L; Mardis ER; Westervelt P; DiPersio JF; Walter MJ; Graubert TA; Ley TJ; Druley T; Link DC; Wilson RK
Nature; 2015 Feb; 518(7540):552-555. PubMed ID: 25487151
[TBL] [Abstract][Full Text] [Related]
20. Clonal architecture of secondary acute myeloid leukemia.
Walter MJ; Shen D; Ding L; Shao J; Koboldt DC; Chen K; Larson DE; McLellan MD; Dooling D; Abbott R; Fulton R; Magrini V; Schmidt H; Kalicki-Veizer J; O'Laughlin M; Fan X; Grillot M; Witowski S; Heath S; Frater JL; Eades W; Tomasson M; Westervelt P; DiPersio JF; Link DC; Mardis ER; Ley TJ; Wilson RK; Graubert TA
N Engl J Med; 2012 Mar; 366(12):1090-8. PubMed ID: 22417201
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
